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In the last decades, a growing body of evidence has been reported concerning the
expression and functional role of hepatocyte growth factor (HGF) on different aspects
of testicular physiology. This review has the aim to summarize what is currently known
regarding this topic. From early embryonic development to adult age, HGF and its receptor
c-Met appeared to be clearly detectable in the testis. These molecules acquire different
distribution patterns and roles depending on the developmental stage or the post-natal
age considered. HGF acts as a paracrine modulator of testicular functions promoting the
epithelium–mesenchyme cross-talk as described even in other organs. Interestingly, it has
been reported that testicular HGF acts even as an autocrine factor and that its receptor
might be modulated by endocrine signals that change at puberty: HGF receptor expressed
by Sertoli cells, in fact, is up-regulated by FSH administration. HGF is in turn able to modify
endocrine state of the organism being able to increase testosterone secretion of both fetal
and adult Leydig cells. Moreover, c-Met is expressed in mitotic and meiotic male germ
cells as well as in spermatozoa.The distribution pattern of c-Met on sperm cell membrane
changes in the caput and cauda epididymal sperms and HGF is able to maintain epididymal
spermmotility in vitro suggesting a physiological role of this growth factor in the acquisition
of sperm motility. Noteworthy changes in HGF concentration in seminal plasma have been
reported in different andrological diseases. All together these data indicate that HGF has
a role in the control of spermatogenesis and sperm quality either directly, acting on male
germ cells, or indirectly acting on tubular and interstitial somatic cells of the testis.
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THE HEPATOCYTE GROWTH FACTOR MACHINERY AND ITS
BIOLOGICAL FUNCTIONS
The hepatocyte growth factor (HGF) is a pleiotropic cytokine orig-
inally purified as a potent mitogen for hepatocytes (1, 2) and
subsequently identified as a “scatter factor” (3, 4). HGF is syn-
thesized as an inactive single chain precursor that is cleaved to
acquire the bioactive disulfite-linked heterodimeric form (2, 5).
One of the most recognized activators of HGF precursor is the
HGF activator protein (HGFA), which is a serine protease able
to cleave immature HGF precursor to form a mature bioactive
HGF (6). Interestingly, HGF activation may be provided also by
active metalloproteinases (MMP2 and MMP9) and by plasmino-
gen activator (PA). More recently, it has been discovered also an
inhibitor of HGF activation (called HGF inhibitor or HAI) that is
a serine protease inhibitor that blocks HGFA activation (7). The
modulation of HGFA and HAI in the tissue microenvironment is
able to maintain the correct HGF availability since HGF has been
established as an important factor for tissue homeostasis (8).
c-Met is the unique HGF receptor and it is normally expressed
by cells of epithelial origin whilst HGF expression has been mainly
found restricted to cells of mesenchymal origin. c-Met receptor
presents tyrosine-kinase activity and, upon HGF stimulation, this
receptor triggers several transduction pathways responsible for
its multiple biological responses including proliferation, motil-
ity, migration, morphogenesis, tubulogenesis, differentiation, and
angiogenesis (8–10). In particular, c-Met activation by its ligand
HGF triggers transphosphorylation of the catalytic tyrosines Tyr
1234 and Tyr 1235, which positively modulate its enzymatic activ-
ity. c-Met c-terminal tail contains tyrosines Tyr 1349 and Tyr 1356,
which represent, when phosphorylated, the multifunctional dock-
ing site of the receptor. These two amino acidic residues are able
to recruit several transducers and adaptors after c-Met activation,
thus explaining the whole spectrum of pleiotropic biological activ-
ities exerted by HGF/c-Met system (11). These transducers interact
with the intracellular multi-substrate docking site of c-Met either
directly, such as GRB2, SHC, SRC, and the p85 regulatory subunit
of phosphatidylinositol-3 kinase (PI3K), or indirectly through the
scaffolding protein Gab1 such as PLC-γ (12–17).
c-Met knock-out mice have provided only partial informa-
tion in the understanding of the role of HGF/c-Met system in
the embryonic development of mammals since this animal model
showed an embryonic lethal phenotype due to severe placental
defects. However, some information was drawn by these knock-
out animals indicating an essential role of this growth factor in
gastrulation, angiogenesis, myoblast migration, and liver devel-
opment (12, 18, 19). The study of HGF/c-Met system expression
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during the mouse organogenesis has provided great insights in
the understanding of HGF function. This system, in fact, has been
found in several developing organs being HGF expressed in the
mesenchyme and c-Met in the epithelial part of the developing
tissue. On the basis of this preliminary observation, it has been
demonstrated and well established that HGF/c-Met system medi-
ates signal exchange between mesenchymal and epithelial cells
in embryonic morphogenesis as well as in post-natal stroma–
parenchyma cross-talk and tissue homeostasis (20). In addition,
HGF has been demonstrated to exert unique developing capability
as a morphogen of tubular structures and inducer of harmonic cell
migratory activities (21–23). Even if HGF could be mainly identi-
fied as paracrine factor in the mesenchyme–epithelium cross-talk,
it has been also found that this growth factor is actively deliv-
ered via blood vessels to injured organs allowing their repair
and homeostasis (24, 25). Besides its action as a hormone, it has
been demonstrated that HGF expression is regulated by blood
hormones, neurotransmitters, and cytokines, such as GH (26),
Norepinephrine (27), and systemic prostaglandin E (28). In addi-
tion, the discovery of HGF/c-Met system in the regulation of
testis and ovary differentiation and physiology has given rise to
an increasing amount of evidences that support the intriguing
hypothesis of a cross-talk among gonadotropins, sex hormones,
and HGF in both the female and male gonads (29, 30). This review
aims to focus on what is known on the implications of HGF in
the autocrine, paracrine, and endocrine regulation of testicular
physiology.
ROLES OF HGF IN THE PHYSIOLOGY OF THE TESTIS
Hepatocyte growth factor/c-Met system has been found expressed
and active during all the phases of pre-natal and post-natal testis
development. The activities of the HGF machinery on the testicu-
lar tissue vary depending on the different phases of both pre-natal
and post-natal ages: these ranges from the modulation of both
steroidogenesis and apoptosis to guiding mitosis, morphogenesis,
and differentiation. Overall, the emerging picture suggests HGF
as one of the growth factors which cooperates at different levels
to support male reproductive health and is deeply involved in the
harmonic control of spermatogenetic process.
HGF/c-MET SYSTEM IN TESTIS EMBRYONIC DEVELOPMENT
As previously stated during pre-natal development, HGF/c-Met
system is expressed and active in a wide variety of developing
organs, such as the liver, lung, pancreas, intestine, and kidney.
HGF transcripts were mainly found localized in the mesenchymal
part of these organs whereas c-Met expression appeared mainly
restricted to the epithelial portion (23), thereby indicating an
important role for HGF in epithelial–mesenchymal interaction
during embryonic morphogenesis. Moreover, it has been reported
that HGF may induce mesenchymal to epithelial cell conversion
(31). Testis develops from the collaboration and the cross-talk of
intermediate mesoderm and celomic epithelium. In addition, its
morphogenesis is characterized by a conversion of mesenchyme
in epithelial cells (for instance Sertoli and Leydig cells) as well
as by a tight cross-talk between its epithelial and mesenchymal
cells. By this point of view, it may be intriguing but not surprising
that HGF/c-Met system has been found during the entire period
of testis embryonic development. What seems noteworthy is that
the distribution patterns and functional roles of this molecular
machinery change in the different morphogenetic phases of the
testicular embryonic development.
Early testicular morphogenesis
Hepatocyte growth factor/c-Met expression has been reported
starting from 11.5 dies post coitum (dpc) and continues through
the entire period of pre-natal development. Actually, at 11.5 dpc
only HGF is present in the celomic epithelium underlying male
urogenital ridges whereas, at the same pre-natal age, c-Met is not
already expressed in the gonads even if it is clearly detectable
in the mesonephric mesenchyme (32, 33). One of the first spe-
cific features of male gonad development is represented by the
mesonephric cell migration toward the developing testis; this cell
migration begins at 11.5 dpc and was described up to 16.5 dpc
in a sex-specific manner (34–37). Consistent with the observed
HGF/c-Met distribution pattern in the early gonad, HGF has been
established as one of the growth factors potentially involved in the
chemo-attraction of mesonephric cells (32, 33, 38) thus collabo-
rating with other growth factors such as FGF9, PDGF, and neu-
rotrophins, to establish the male differentiation niche for somatic
and germ cells (38–41) (Figure 1).
Testicular cord morphogenesis
Seminiferous cord formation is the critical morphogenetic event
of testis development. To obtain a correct cord formation, the
previously reported migration of mesenchymal cells from the
mesonephros into the developing gonads is necessary (37, 42).
However, this complex phenomenon requires the harmonic coor-
dination of several biological processes such as proliferation, dif-
ferentiation, and polarization of pre-Sertoli cells present in the
“morphologically indifferent”gonad and their association with the
primordial germ cells. The coordination of these events requires
a tight epithelium–mesenchyme cross-talk that is guaranteed by
the action of specific local growth factors (43–45) and HGF has
been indicated as one of them. Testicular cords begin to orga-
nize at 12.5 dpc. At the same developmental age, c-Met starts
to be expressed by the developing testis and seems to be con-
fined in the testicular cords of this organ. As reported for other
organs, at the same stage of development, HGF expression is
present in the differentiating stroma and in differentiating myoid
cells confirming the capability of HGF/c-Met system to mediate
epithelium–mesenchyme exchange (32, 33). Using organ culture
of indifferent male urogenital ridges, it has been demonstrated that
HGF is able to mediate testis differentiation and testicular cord for-
mation in ex vivo organ culture condition (32, 33, 38). Since this ex
vivo differentiation is the result of the coordination of cell migra-
tion, cell proliferation, and tubulogenesis, using in vitro assays
able to discriminate between these different phenomena, it has
been established that HGF is able to trigger all these events, again
confirming the multiple biological activities that are mediated by
this molecular machinery (32, 33, 38) (Figure 1).
Fetal Leydig cell differentiation and endocrine implications
c-Met receptor continues to be expressed by testicular cord up to
15.5 dpc. It is interesting to notice that in the late part of pre-natal
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FIGURE 1 | Picture summarizing the main effects exerted by HGF during embryonic testis development. Purple signal in the developing urogenital ridges
at different pre-natal stages indicates c-Met mRNA expression. Gr, genital ridge; Ts, testis; Ms, mesonephros; Ep, epididymis.
development (since 17.5 dpc to birth) c-Met distribution pattern
drastically changes, being down-regulated in the testicular cords
and up-regulated in the interstitial fetal Leydig cells (46). HGF is
always present in the interstitial compartment, but, interestingly,
it is not produced by mouse fetal Leydig cells. Thus HGF acts as a
paracrine factor even on differentiating fetal Leydig cells reproduc-
ing in the interstitial compartment the epithelium–mesenchyme
cross-talk present between interstitium and testicular cords in
the embryonic stages before this pre-natal age. Actually, steroid-
producing fetal Leydig cell lineage starts to be detectable in the
testis early on 12.5 dpc but their differentiation process involves
all the further stages of pre-natal development when they increase
in number and gradually acquire the capability to modulate andro-
gen secretion in response to local and endocrine cues (39, 47, 48).
It is worth to highlight that when mesenchyme derived fetal Ley-
dig cells start to acquire their fully differentiated phenotype in
late embryogenesis (49), they start to express c-Met on their sur-
face. The latter observation allowed to hypothesize a role for this
growth factor in the modulation of testicular pre-natal endocrine
function. In rodents, in fact, fetal masculinization and increase
of plasma androgens occur before the hypothalamic–pituitary–
gonadal axis to be functional (50) since LURKO mice (that lack
the luteinizing hormone receptor) have normal androgen levels
and testicular phenotype at birth (51). Thus there is a common
agreement in the scientific community that states the differen-
tiation of fetal Leydig cells is under the control of local growth
factors and HGF seems to be one of them. In fact, in 17.5 and 18.5
dpc testicular organ culture, HGF is able to stimulate testosterone
production (46) and fetal Leydig cell survival and full develop-
ment (52). Noteworthy at 15.5 dpc, when c-Met is not detectable
on fetal Leydig cells but is still expressed in seminiferous cords,
HGF has been demonstrated not able to modify testosterone secre-
tion in testicular organ culture. From these data HGF can be
numbered besides PDGF, DHH, TGF-β, and IGF-I as one of the
growth factors responsible of the normal pre-natal steroidogenesis
(39, 48, 52–55).
This phenomenon may be relevant for the onset of the first
cross-talk among gonad, hypothalamus, and pituitary gland, and
potentially involved in the acquisition of secondary sex-specific
features and brain testosterone imprinting (Figure 1).
HGF/c-MET SYSTEM IN THE PHYSIOLOGY OF POST-NATAL TESTIS
Even if the studies on pre-natal morphogenetic functions of HGF
have been established using mouse models, the post-natal roles of
HGF on testicular physiology have been determined mainly using
rats since testicular cell isolation is better characterized for this
animal model. Intriguingly, many parallel mechanisms exist com-
paring ovarian and testicular function and some of them, with
particular attention to endocrine function, will be highlighted in
this part of the review.
Sertoli cells
Correct Sertoli cell differentiation is crucial in order to maintain
the local microenvironment necessary to sustain spermatogenetic
process (56, 57). Several growth factors have been described as
local modulators of Sertoli cell physiological niche and HGF can
be numbered in this cohort since it has been demonstrated as a
paracrine and autocrine modulator of Sertoli cell physiology. In
the rat, c-Met mRNA and protein were detected in the post-natal
testis starting from 10 dies post partum (dpp) even if they appear
on Sertoli cells not before 25 dpp and their expression increases at
35 dpp. As previously reported in the embryonic testis, also in the
post-natal testis the main source of HGF seems to be represented
by the interstitial cells and by the myoid cells, reproducing the
epithelium–mesenchyme cross-talk observable during the mor-
phogenesis of the testis. Despite this observation, in the post-natal
testis, HGF has often been demonstrated to be expressed also by
the same cell lineages that express c-Met and Sertoli cells are not
an exception. These data suggest that HGF levels could be finely
regulated by different testicular cell types and that the action of
this factor is not only paracrine but seems to be also autocrine
and maybe endocrine. Interestingly, dissociated rat Sertoli cells as
well as the Sertoli cell line SF7 cultured in the presence of HGF,
are able to organize in tubular-like structures showing, even in the
post-natal testis, the morphogenetic and tubulogenic ability of this
growth factor (58, 59). This observation demonstrates that HGF
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FIGURE 2 | Picture summarizing the main effects exerted by HGF on post-natal testis derived cells. A hematoxylin–eosin stained section of rodent adult
testis is also reported. SC, Sertoli cells; LC, Leydig cells; MyC, myoid cells; Spg, spermatogonia; Spz, spermatozoa.
is able to guarantee the right cue for the maintenance of correct
Sertoli cell polarization that is one of the parameters showing full
differentiated Sertoli cell phenotype. These data together with the
age of onset of Sertoli cell sensitivity to HGF have strongly sug-
gested that this growth factor may be involved in testicular cord
lumen and blood–testis barrier (BTB) formation. This particular
topic will be fully expanded in a paragraph below.
Sertoli cells are one of the key somatic actors of endocrine
hypothalamus–pituitary–gonadal axis cross-talk being able to pro-
duce and secrete estrogens in response to FSH and thus to regulate
the spermatogenetic process. As HGF has been proposed as one
of the factors able to modify Sertoli cell physiology and to main-
tain their differentiated phenotype, it is conceivable to hypothesize
that this factor has a role in the modulation of gonad–pituitary
cross-talk. It was suggested by Zachow and Uzumcu in 2007 (30),
that there is an intriguing parallelism between male and female
gonad that hypothesizes some endocrine implications of HGF in
the physiology of both organs. It has been reported, also, that HGF
can down-modulate ovarian steroidogenesis suppressing FSH-
dependent 17β-estradiol production by directly impairing CYP19
enzyme (60, 61). It is well known that Sertoli cells represent the tes-
ticular counterpart of granulosa cells and are the testicular source
of 17β-estradiol. Sertoli cells are capable to produce the greatest
quantity of 17β-estradiol in the first 10–20 days of post-natal age
(62). Interestingly, HGF together with c-Met is not present on Ser-
toli cells at post-natal day 10 (63, 64) whilst both the receptor and
the ligand appear expressed by Sertoli cells since post-natal day 25
(64, 65), which is the time when 17β-estradiol production by Ser-
toli cells begins to be reduced (62). All together these observations
allow to hypothesize that HGF could locally control in vivo Sertoli
cell 17β-estradiol production in a similar way of what observed in
granulosa cells. Consistent with these data, FSH has been demon-
strated able to up-regulate c-Met expression in Sertoli cell cultures
(65) whose activation in turn suppresses, following this hypothe-
sis, Sertoli cells 17β-estradiol synthesis. The proposed mechanism,
that deserves further investigations, suggests that HGF/c-Met sys-
tem may be responsible for a local modulation of FSH-dependent
estrogen production, modulating both enzyme activity and c-Met
receptor availability (Figure 2).
Germ cells and spermatozoa
It has been reported by several groups that c-Met is expressed
in both human and rodent male germ cells: this observation is
interesting since it means the expression of this receptor is con-
served at least among mammals (66–68). In rats, this receptor is
always present during spermatogenetic process from spermato-
gonia to spermatozoa. HGF has been shown to control germ cell
mitotic activity being able to significantly increase spermatogonial
cell proliferation from 8 to 30 days old rat testis in ex vivo organ
culture. This result on spermatogonia cells appears to be more
relevant highlighting that the HGF activator inhibitor (HAI-2)
is expressed exclusively in primary spermatocytes (69) strongly
indicating that mitotic germ cells need HGF signal whereas at the
beginning of meiotic process this proliferating cue needs to be
inhibited in order to allow germ cell meiotic entry.
Germ cell apoptosis is finely controlled in the testis in order to
guarantee the best selection of differentiating male gametes and
HGF has been demonstrated to be involved even in the control
of this biological process. This growth factor, in fact, has been
demonstrated to act also as a survival factor for male germ cells
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since it is capable to significantly decrease germ cell apoptosis
(67). The lowest protective effect (35% reduction of apoptosis)
was found in late prepubertal rats and this finding is probably due
to the fact that the highest level of apoptosis has been described
at this age (70). Alternatively, this observation could be due to
the presence of a more complex network of pro-apoptotic and
anti-apoptotic factors present in the older animals (Figure 2).
This result on healthy animals is reinforced by Goda and cowork-
ers who studied a rat experimental cryptorchid model (71). This
pathology is characterized by spermatogenic failure and germ cell
loss. The adenovirus-mediated HGF gene transfer in the testis of
these animals induced over-expression of HGF and significantly
decreased apoptotic germ cell number, restoring spermatogenesis
and testicular weight.
It is well known that germ cell proliferation and survival are
controlled by endocrine signals: for instance FSH stimulates sper-
matogonial proliferation both in vivo and in vitro (72–74). In
addition, testosterone and FSH regulate germ cell apoptosis (75,
76) probably acting via somatic cells considering the absence on
the germ cells of their respective receptors (77, 78). By this point
of view, HGF may be considered one of the local cytokines already
identified (57, 79–83) that collaborates with the endocrine signals
to promote the correct male germ cell homeostasis.
There has not been a report of any effect of HGF on meiotic
germ cells, even if they express c-Met receptor on their surface (67).
However, several groups have reported that c-Met is expressed on
the surface of rat (66), and human epididymal spermatozoa (68,
84) and that HGF is present in mouse (85), rat (66), and human
(86) epididymis. It is fair to say that literature data on the role of
HGF on epididymal spermatozoa are often controversial. The first
finding that strongly suggested a role of HGF in epididymal sperm
maturation was reported by Naz and coworkers in 1994 (85). This
group showed a specific region distribution pattern of HGF in
the mouse epididymal tract with the highest levels of the growth
factor in the distal corpus and cauda, where sperms acquire their
motility. In the same study, HGF was found able to slightly induce
cell motility on immotile sperms. Noteworthy, also c-Met distrib-
ution pattern on sperm surface seems to change from testicular to
caput and cauda epididymal spermatozoa in rats (66). In addition,
the previously mentioned effect on sperm motility was, at least in
part, confirmed on rat epididymal sperms in which HGF has a
positive effect on the in vitro maintenance of epididymal sperm
motility even if, actually, the factor was not able to significantly
increase the percentage of motile cells (66). Interestingly, c-Met
receptor on human sperm has been found activated indicating
that the HGF/c-Met system is functionally active in epididymal
spermatozoa (84). However, the same motogenic effect reported
in rodents failed to be demonstrated on human sperms (87) and
the role of this growth factor on human sperm physiology is still a
matter of debate (Figure 2). It was suggested that modifications in
HGF seminal plasma concentration could be related with differ-
ent andrological diseases and male infertility, but actually as in this
case conflicting data are reported in the literature (87–89). It is fair
to notice that male infertility could be due to really different causes:
it is likely that the reported literature controversy may depend on
the difficulties in classification of andrological diseases considered
eligible for this particular study by the different research groups.
Further studies are needed to better clarify this point that deserves
to be deeper investigated.
Blood–testis barrier
The described morphogenic and motogenic effect on cultured pre-
natal and post-natal Sertoli cells allowed to hypothesize that HGF
may modulate junctional capability of this cell type. It is well
known, in fact, that HGF is a “Scatter Factor” able to modulate
junctional behavior of target cells. In adult mammalian testes,
Sertoli cells form junctional complexes with neighboring Sertoli
cells that have been described from a long time (90). These junc-
tional complexes consist of tight junctions and testis specific cell
to cell actin based anchoring junctions which are both involved
in the formation of the BTB. BTB separates the seminiferous
epithelium in two different niches: the basal compartment, that
encloses mitotic spermatogonia, and the adluminal compartment
that encloses male meiotic germ cells. BTB integrity is necessary
to allow the correct spermatogenic process, but its structure is
highly dynamic. Junctional complexes of BTB, in fact, are able to
disassemble and reassemble to allow the passage of pre-leptotene
spermatocytes across the barrier (90, 91). In the last years, mul-
tiple reports from different laboratories have indicated that BTB
permeability and physiological dynamics are regulated by a com-
plex interaction of bioactive molecules including gonadotropins,
testosterone, TGF-β, TNF-α, and interleukin-1a (92–98). Since
2008, HGF must be included in this number of factors (58, 99). In
pubertal and adult rats it has been reported, in fact, that HGF is
involved in the disassembling of the polygonal structures formed
by occludin around the Sertoli cells. Moreover, it was demon-
strated a quantitative occludin decrease in the tubules cultured in
the presence of HGF by means of both confocal microscopy and
Western blot analysis. In addition, HGF modifies the position of
the tight junctions: it is indicated by the shift in the position of the
occludin within the tubule treated with the growth factor com-
pared to the controls. These data indicate a role of HGF in the
modification of Sertoli cells junctional behavior. Interestingly, in
adult rats HGF is maximally expressed at stages VII–VIII of the
cycle, when germ cells traverse the BTB, whereas its levels fall in the
subsequent stages IX–XII and XIII–I (58). This observation gives
rise to the intriguing hypothesis that HGF produced by Sertoli cells
could autocrinally regulate BTB in a stage dependent manner. It
is relevant to highlight that HGF mediated BTB dynamism may
be potentially due not only to a direct motogenic effect of HGF
on Sertoli cells but also to the capability of HGF to modify the
seminiferous tubule microenvironment promoting the increase of
TGF-β active fraction. This phenomenon could be ascribed, at least
in part, to the uPA level increase mediated by HGF in seminiferous
tubule cultures (58, 99) (Figure 2).
Myoid cells
Myoid cell lineage was the first isolated testicular cell type in which
HGF/c-Met system has been discovered (63). Even if HGF has
always been found expressed both in pre-natal and post-natal
myoid cells (33, 63, 64), c-Met was detectable only in post-natal
cells indicating a paracrine function during embryonic develop-
ment and a paracrine/autocrine role in post-natal testis. Note-
worthy, myoid cells isolated from prepubertal rat testis (10 and
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20 days old rats) express c-Met receptor at high level whereas
the expression level decreases in pubertal and adult myoid cells
(35 and 60 days old rats). Consistent with these results, HGF is
able to induce a faster cell spreading of prepubertal myoid cells
but not able to modify this parameter on myoid cells isolated
from pubertal animals (Figure 2) (64). Despite myoid cells were
the first testicular lineage in which HGF/c-Met system has been
described, the role exerted by this machinery in their physiology
needs to be better investigated. Probably, one of the roles exerted
by myoid cells is to provide a source of this factor both for Leydig
and Sertoli cells.
Leydig cells
As well as mouse fetal Leydig cells, also Leydig cells isolated
from pubertal rats expressed c-Met receptor (100). Physiologi-
cal activity of HGF on pubertal rat Leydig cells presents some
similarities with their fetal counterparts: in particular as HGF
has been demonstrated to promote basal testosterone secretion
and Leydig cell survival (100) both in Leydig cell primary culture
and in ex vivo organ culture. Intriguingly, the steroid modula-
tor activity is not confined in male gonad but was also described
in theca cells, which are the Leydig cell ovarian counterparts. In
rat theca cells, in fact, HGF suppressed LH-dependent andros-
terone secretion, while stimulated basal and LH-induced prog-
esterone production (60). It is fair to highlight the parallelism
between male and female gonad and to notice that steroid pro-
duction modulation in response to local cues is quite relevant for
gonad physiology since sex hormones are not only important for
endocrine homeostasis via pituitary–gonadal axis cross-talk but
also act as paracrine regulators of male and female gametogene-
sis. In addition, local increase of testosterone could be important
for BTB dynamism that, as previously stated, was also directly
modulated by HGF.
Besides its effect on testosterone secretion, it is worth men-
tioning that HGF exerts a broader effect on Leydig cell secretory
activities: HGF administration to isolated rat Leydig cells was able
to increase the secretion of active form of several proteases such as
MMP2 and uPA (101). Interestingly, HGF administration was also
able to increase active TGF-β. Viewed together these data suggest
that increased amount of active TGF-β could not be a direct effect
of HGF but a consequence of the HGF-dependent increased uPA
and MMP2 activity (102–104).
Different types of molecules can be substrates of MMPs includ-
ing growth factors, tyrosine-kinase receptors, extracellular matrix
proteins, and cell adhesion molecules. HGF administration on iso-
lated Leydig cells significantly reduces the amount of fibronectin
indicating that this growth factor might modify interstitial extra-
cellular matrix components and in turn changes significantly
adhesive microenvironment and cytokine availability (Figure 2).
It is fair to highlight that extracellular matrix homeostasis is nec-
essary for spermatogenesis and that a thickened lamina propria
has been reported associated with impaired spermatogenesis (105)
and that HGF has demonstrated to have anti-fibrotic effect in
the regulation of extracellular matrix composition even in other
organs (8). All together, the presented data indicate a relevant role
of HGF in the regulation of Leydig cell metabolic activities and
in the composition of the interstitial tissue. The reported results
strongly indicate that HGF/c-Met system is implicated in the local
control of endocrine testicular machinery.
CONCLUDING REMARKS
Hepatocyte growth factor has been well established as a key reg-
ulator of the development and homeostasis of many organs. An
increasing amount of evidences is demonstrating its important
role in several aspects of pre-natal and post-natal testicular phys-
iology. A huge job has been done but we must deal with a major
one to figure out what might be the implications of this factor in
the reproductive health of human beings. A better understanding
of the molecular mechanisms carried out in vivo by this growth
factor could be a useful prerequisite in order to address idiopathic
andrological diseases.
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